Startups
OvaScience.com is for sale on Spaceship. Secure checkout and quick transfer. See all purchase options. No hidden fees.
Overview
Location
United States, California, South San Francisco
Employees
51-200
Total raised
$37M
Founded date
2011
Investors 3
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Bessemer Venture Partners | bvp.com | |
| Jul 18, 2021 | General Catalyst | generalcatalyst.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 5, 2018 | Sanuj Ravindran to lead PellePharm as CEO; Paul Hastings leaves OncoMed; Moderna taps John Mendlein as president | Sanuj Ravindran → A new president and CEO, Sanuj Ravindran, will lead PellePharm into this year’s Phase III trial for its skin cancer drug. PellePharm, which specializes in rare genetic dermatological conditions, has re... |
| Jan 4, 2018 | Biotech investapalooza continues with more venture rounds for startups; OvaScience cuts half of its workforce (again) | Editor’s note: We here at Endpoints News pride ourselves on providing some comprehensive accounts of all the venture cash flowing into biotech companies, but this week that’s become more than a challenge. In just a matter ... |
| May 16, 2017 | Scientists 3D-printed ovaries and made mouse babies | Scientists from Northwestern University have developed a bioprosthetic ovary using 3D-printing technology and produced living, breathing mouse offspring from them. Northwestern’s Feinberg school of medicine and McCormick school of engineeri... |
| Apr 30, 2013 | Women to watch: MedCity News’s nominees for 40 women over 40 | “…where our wealth of knowledge and know-how can move innovation into overdrive. It is a time where we are supremely motivated to do not just for ourselves, but for others, as we ask the question, What can I do to make my life really count?... |
| Jul 16, 2012 | Investors back female fertility treatment that may ‘reenergize’ eggs using stem cells | Based on infertility research by Jonathan Tilly at Massachusetts General Hospital, OvaScience’s lead program isolates a certain egg-producing stem cell found in the ovary and extracts the cells’ mitochondria, their main source of energy. As... |
| Apr 4, 2012 | OvaScience Secures $37M in Series B | CAMBRIDGE, MA, Fertility company focused on the discovery, development and commercialization of novel treatments for infertility, announced that it has completed a $37 million Series B financing, led by General Catalyst. >> Click h... |
| Apr 4, 2012 | OvaScience Completes $37M Series B Financing Round | OvaScience, a Cambridge, Mass.-based fertility company focused on the discovery, development and commercialization of novel treatments for infertility, has completed a $37m Series B financing. The round was led by General Catalyst, with par... |
| Women to watch: MedCity News’s nominees for 40 women over 40 | One of the first things I learned in my conversations with industry insiders after joining MedCity News was this: while you might find a lot of young people starting health IT companies, most life science entrepreneurs tend to be an older s... | |
| Investors back female fertility treatment that may ‘reenergize’ eggs using stem cells | A company’s new technique to improve female infertility treatment based on the controversial idea that women aren’t in fact born with a finite number of eggs is getting the attention of investors — to the tune of more than $38 million raise... |
Reviews 0
FAQ about OvaScience
When was OvaScience founded?
OvaScience was founded in 2011.
How much funding has OvaScience raised?
OvaScience has raised $37M in total across 1 funding round.
Who has invested in OvaScience?
Parsers VC lists 3 investors of OvaScience, among them General Catalyst and Bessemer Venture Partners.
What has the press written about OvaScience?
Parsers VC has collected 10 articles mentioning OvaScience, among them “Sanuj Ravindran to lead PellePharm as CEO; Paul Hastings leaves OncoMed; Moderna taps John Mendlein as president” (Jan 5, 2018) and “Biotech investapalooza continues with more venture rounds for startups; OvaScience cuts half of its workforce (again)” (Jan 4, 2018).
Is OvaScience still active?
OvaScience is probably closed: its latest activity on Parsers VC dates from Jul 18, 2021.